Cargando…
Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist
Introduction: Orchidectomy is currently the preferred method to induce bone loss in preclinical male osteoporosis model. Gonadotropin-releasing hormone (GnRH) agonists used in prostate cancer treatment can induce testosterone deficiency but its effects on bone in preclinical male osteoporosis model...
Autores principales: | Mohamad, Nur-Vaizura, Che Zulkepli, Muhammad Afiq Amani, May Theseira, Krystine, Zulkifli, Norain, Shahrom, Nur Quraisha, Ridzuan, Nurul Amni Mohamad, Jamil, Nor Aini, Soelaiman, Ima-Nirwana, Chin, Kok-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835701/ https://www.ncbi.nlm.nih.gov/pubmed/29511366 http://dx.doi.org/10.7150/ijms.22732 |
Ejemplares similares
-
Effect of tocotrienol from Bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin
por: Mohamad, Nur-Vaizura, et al.
Publicado: (2018) -
A concise review of testosterone and bone health
por: Mohamad, Nur-Vaizura, et al.
Publicado: (2016) -
Self-emulsified annatto tocotrienol improves bone histomorphometric parameters in a rat model of oestrogen deficiency through suppression of skeletal sclerostin level and RANKL/OPG ratio
por: Mohamad, Nur-Vaizura, et al.
Publicado: (2021) -
Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence
por: Mohamad, Nur-Vaizura, et al.
Publicado: (2020) -
The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence
por: Wong, Sok Kuan, et al.
Publicado: (2019)